With FDA nod, Ridgeback's Ebanga joins Regeneron's Inmazeb in the Ebola-fighting arsenal! The FDA has approved a second Ebola treatment, Ebanga by Ridgeback Biotherapeutics! $REGN#Ebola#FDAbit.ly/3nM4JFn
As Lilly gears up for key 2022 launches, Trulicity, Taltz and more drive solid growth! Overall, Lilly's sales beat consensus estimates by about $170 million! $LLY#pharma#diabetes#Alzheimerbit.ly/3Ck9woy
Amplia Therapeutics secures renowned oncology drug development expert as clinical advisor! Dr Iglesias has more than 30 years’ experience in the pharmaceutical industry and has focused on creation of new oncology drugs! $ATX.AX$INNMF#PancreaticCancerbit.ly/3pAke70
Loving the @ASCO eLearning podcast and recommend other #hemonc trainees to check it out - current topics with experts, perfect for the 🚶🏻♀️or 🚙 to work!
BioNTech to start building mRNA vaccine manufacturing plant in Africa in mid-2022! The German biotech already ordered the initial assets and finalized planning for the facility! $BNTX$PFE#mRNA#COVID19Vaccine#Africabit.ly/2ZuoLgs
Johnson & Johnson goes local to help Black, Hispanic patients left behind by health inequality! There is a concerted effort across the field to try to right or at least level the past wrongs! $JNJ#healthcare#inequalitybit.ly/3meTAyd
EMA starts rolling review of Merck's molnupiravir, continuing rapid regulatory response to COVID-19 antiviral data! The large pharma seeking approval on strength of data on 762 patients at high risk of disease progression! $MRK#Covid19#antiviral#biotechbit.ly/3jAkBuB
To expand access to a promising Covid-19 pill, Merck licensed it to a U.N.-backed group that will pick other companies to make it for low- and middle-income countries wsj.com/articles/promising-c…
Juventas Cell Therapy closes a $63 million funding round as it eyes a big push for blood cancer hopeful! This comes amid a biotech boom in China, which is looking to boost its internal life science reputation! #biotech#celltherapy#cancer#Chinabit.ly/2ZeuDtT
When she was just six weeks pregnant, Gretchen Lee Herrera learned she had breast cancer.
How her MD Anderson care team put her at ease about her own health and the health of her unborn baby: fal.cn/3j2Dt @drmediget #BreastCancer#EndCancer
Novartis looks for silver lining in $2 billion canakinumab repurposing after 2nd lung cancer failure! Still, the data support further evaluation of the drug in lung cancer! $NVS$pharma#lungcancer#chemotherapybit.ly/2ZnRMKg
Impressive! Thanks for sharing! @JohnCendpts
"A quiet cardio upstart makes some noise, getting $300M from Bain and diving deep into the clinic - with some real money for pipeline deals"
A quiet cardio upstart makes some noise, getting $300M from Bain and diving deep into the clinic -- with some real money for pipeline deals
endpts.com/a-quiet-cardio-up…
AstraZeneca's Imfinzi strikes immunotherapy's first win in bile duct cancer, with Merck's Keytruda behind! Bile duct cancer marks drug's second positive gastrointestinal cancer readout in just a few days! $AZN$MRK#cancer#pharma#Immunotherapybit.ly/3CfMTSa
FDA Puts Ultimovac's Cancer Vaccine Support Therapy on Fast Track! The designation is based on data from two Phase I trials, which showed the drug to be safe, demonstrating early efficacy! $ULTI.OL#cancer#vaccine#FDAbit.ly/3jtUbKH